Cleveland BioLabs, Inc(NASDAQ:CBLI) 
Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. Its proprietary platform of toll-like immune receptor activators (TLR) has applications in mitigation of radiation injury, ...
Website: http://www.cbiolabs.com
Full Time Employees: 2 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.00
H 0.00
L 0.00
C 0.00
V 13,770
10EMA
20EMA
60EMA
120EMA
250EMA